Implications of catecholamine systems of the brain in schizophrenia.
D000661:Amphetamine / Q000378:metabolism; D001921:Brain / Q000378:metabolism*; D002395:Catecholamines / Q000378:metabolism*; D002746:Chlorpromazine / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D006634:Histamine H1 Antagonists / Q000378:metabolism; D006719:Homovanillic Acid / Q000378:metabolism; D006801:Humans; D008995:Monoamine Oxidase / Q000378:metabolism; D010276:Parasympatholytics / Q000378:metabolism; D012559:Schizophrenia / Q000378:metabolism*; D011984:Sensory Receptor Cells; D014149:Tranquilizing Agents / Q000378:metabolism
D002395:Catecholamines; D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D014149:Tranquilizing Agents; D004295:Dihydroxyphenylalanine; D000661:Amphetamine; D008995:Monoamine Oxidase; D002746:Chlorpromazine; D004298:Dopamine; D006719:Homovanillic Acid